User login
Enter your username and password here in order to log in on the website:
Please note: While some information will still be current in a year, other information may already be out of date in three months time. If you are in any doubt, please feel free to ask.
VX-661, for patient with the F508del mutation
- Question
- Regarding the phase II study of VX-661, for patient with the F508del mutation (deltaF508), which should begin during the second semester 2011:
- Is it the same study than the one where VX-770 is used in combination with VX-809? Or is it a different study?
- Is study is also specific for patients homozygous F508del?
- Is there a website to know the inclusion criteria?
Thanks for your response
- Answer
- Hello,
The Phase II announced on the Vextex laboratory website (www.vrtx.com/current-projects/drug-candidates/VX-661.html) is a trial different from the one combining VX-770 and VX-809. To date we have no more information on starting a new trial with VX-661 which is a new corrector.
Best regards
Anna Ronayette - 12.04.2011
